Mommox Rino (Mometasone Furoate)

Mometasone furoate binds to glucocorticoid receptors in the nasal mucosa, modulating gene transcription to suppress inflammatory cytokines and immune cell activity. This localized anti‑inflammatory action decreases edema and mucus production in the nasal passages.

The specific dosing regimen for Mommox Rino is determined by the prescribing healthcare professional based on the patient’s age, severity of symptoms, and clinical response. Patients should follow the exact instructions provided on the prescription label.

Safety data for mometasone furoate nasal spray in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Mommox Rino.

To order Mommox Rino, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mommox Rino contains mometasone furoate, a high‑potency glucocorticoid with a favorable local anti‑inflammatory profile. Compared with lower‑potency agents such as fluticasone, mometasone may achieve symptom control with a similar or lower dosing frequency, but individual response varies and choice should be guided by clinical judgment.

Store Mommox Rino at room temperature, below 25 °C, in the original packaging. Protect the spray from moisture, direct sunlight, and extreme temperatures. Keep the device upright and avoid freezing. Do not use the product after the expiration date printed on the label.

Mommox Rino is administered as a nasal spray. The patient should gently blow the nose, insert the tip into one nostril, close the opposite nostril, and spray the prescribed number of actuations while breathing in gently. The process is repeated in the other nostril if directed by the prescriber.

Serious risks, though uncommon, include nasal septal perforation, vision changes such as cataracts, and severe allergic reactions (anaphylaxis). Patients should seek immediate medical attention if they experience persistent nosebleeds, unusual eye symptoms, or signs of an allergic reaction such as swelling, rash, or difficulty breathing.

Mommox Rino should be avoided in individuals with known hypersensitivity to mometasone furoate or any component of the formulation. It is also contraindicated in patients with active untreated fungal, bacterial, or viral infections of the nasal passages until the infection is resolved.